JPRN-jRCTs031180147进行中（未招募）4 期
Efficacy of sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in the adults with immunocompromising conditions -A double blind randomized controlled trial- - CPI study
Maruyama Takaya0 个研究点目标入组 2,000 人开始时间: 2019年2月22日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 19age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Immunocompromised patients >=19 years based on the recommendation of ACIP in 2012 [3]
- •1. Patients with human immunodeficiency virus infection
- •2. Patients with hematologic malignancy (leukemia, lymphoma or multiple myeloma)
- •3. Patients with generalized malignancy
- •4. Patients with congenital or acquired immunodeficiency
- •5. Patients with chronic renal failure needed hemodialysis
- •6. Patients with solid organ transplant
- •7. Patients with diseases requiring treatment with systemic corticosteroids >= 14days
- •8. Patients with diseases requiring treatment with immunosuppressive drugs
排除标准
- •1) Patients given pneumococcal vaccine within 5 years
- •2) Patients hypersensitive to vaccine components.
- •3) Patients who had Guillain-Barre syndrome or acute disseminated encephalomyelitis previously
- •4) Women with pregnancy or lactation
- •5) Patients judged by the investigator to be inappropriate for inclusion for any other reason including severe disease
研究者
相似试验
招募中
4 期
Efficacy of sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in the adults with immunocompromising conditions-A double blind randomized controlled trialimmunocompromised patientsJPRN-jRCT1090220246ational Hospital Organization Mie National2,000
招募中
不适用
Targeted enhanced surveillance to observe vaccine impact against PneumococcusStreptococcus pneumoniaeEmpyemaInfection - Studies of infection and infectious agentsRespiratory - Other respiratory disorders / diseasesPublic Health - Other public healthPneumoniaACTRN12614000354684niversity of New South Wales2,200
进行中（未招募）
1 期
PCV immunisation for children with leukaemiaChildhood Acute Lymphoblastic LeukaemiaEUCTR2009-011587-11-GBniversity Hospital Southampton NHS Foundation Trust118
尚未招募
不适用
A study to find out the amount of Naloxone which is required to effectively block the addictive effects of Buprenorphine when administered intravenously.CTRI/2017/06/008817ational Drug Dependence Treatment Centre AIIMS12
进行中（未招募）
不适用
Efficacy and safety of subsequent treatment with 90Y-Zevalin in patients with stage II to IV follicular non-Hodgkin?s lymphoma in partial or complete remission after oral fludarabine and mitoxantrone front-line treatment. A phase II prospective, multicenter, open-label study.Remission induced (CR or PR) stage II to IV follicular non-Hodgkin?s lymphoma patients.MedDRA version: 6.1Level: PTClassification code 10003904EUCTR2004-002211-92-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI